Cargando…
Capture of circulating metastatic cancer cell clusters from a lung cancer patient can reveal a unique genomic profile and potential anti-metastatic molecular targets: A proof of concept study
Metastasis remains the leading cause of cancer deaths worldwide and lung cancer, known for its highly metastatic progression, remains among the most lethal of malignancies. The heterogeneous genomic profile of lung cancer metastases is often unknown. Since different metastatic events can selectively...
Autores principales: | Kouhmareh, Kourosh, Martin, Erika, Finlay, Darren, Bhadada, Anukriti, Hernandez-Vargas, Hector, Downey, Francisco, Allen, Jeffrey K., Teriete, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541091/ https://www.ncbi.nlm.nih.gov/pubmed/37781582 http://dx.doi.org/10.1101/2023.09.19.558270 |
Ejemplares similares
-
Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine
por: Barbolosi, Dominique, et al.
Publicado: (2017) -
Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer
por: Cardinali, Barbara, et al.
Publicado: (2022) -
The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study
por: Stebbing, Justin, et al.
Publicado: (2013) -
Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids:
A Proof of Concept
por: Pelosi, Giuseppe, et al.
Publicado: (2019) -
Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease—the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry
por: Stangl, Stephanie, et al.
Publicado: (2020)